Integrating genomic features for non-invasive early lung cancer detection
暂无分享,去创建一个
Ash A. Alizadeh | Tej D. Azad | Natalie S. Lui | R. Tibshirani | R. West | C. Liu | G. Berry | A. Leung | J. Shrager | J. Chabon | Emily G. Hamilton | D. Kurtz | M. S. Esfahani | E. Moding | H. Stehr | J. Schroers-Martin | B. Nabet | Binbin Chen | A. Chaudhuri | A. Hui | M. Jin | Diego Almanza | Young-Jun Jeon | Monica Nesselbush | Lyron Co Ting Keh | Rene F. Bonilla | C. Yoo | R. Ko | E. Chen | D. Merriott | P. Massion | A. Mansfield | J. Jen | Hongzheng Ren | Steven H. Lin | C. L. Costantino | Risa Burr | S. Gambhir | K. Jensen | J. Neal | H. Wakelee | B. Loo | C. Kunder | M. Berry | V. Nair | D. Haber | L. Sequist | M. Diehn | N. Lui | T. Azad
[1] C. Lam,et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. , 2002, Clinical chemistry.
[2] Richard Simon,et al. Roadmap for developing and validating therapeutically relevant genomic classifiers. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[4] Jeff Mellen,et al. High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.
[5] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[6] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[8] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[9] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[10] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[11] P. Marcus,et al. Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[12] D. Aberle,et al. Results of initial low-dose computed tomographic screening for lung cancer. , 2013, The New England journal of medicine.
[13] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[14] Ahmedin Jemal,et al. Annual number of lung cancer deaths potentially avertable by screening in the United States , 2013, Cancer.
[15] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[16] V. Moyer. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.
[17] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[18] E. Kazerooni,et al. Performance of Lung-RADS in the National Lung Screening Trial , 2015, Annals of Internal Medicine.
[19] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[20] V. Wong,et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.
[21] Ash A. Alizadeh,et al. Integrated digital error suppression for improved detection of circulating tumor DNA , 2016, Nature Biotechnology.
[22] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[23] P. Hainaut,et al. Somatic TP53 Mutations in the Era of Genome Sequencing. , 2016, Cold Spring Harbor perspectives in medicine.
[24] Universal Patterns of Selection in Cancer and Somatic Tissues , 2017, Cell.
[25] Ash A. Alizadeh,et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer Discovery.
[26] Sam Angiuoli,et al. Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.
[27] Ashwini Naik,et al. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.
[28] Ahmedin Jemal,et al. Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.
[29] Yue Han,et al. AfterQC: automatic filtering, trimming, error removing and quality control for fastq data , 2017, BMC Bioinformatics.
[30] Keval Patel,et al. Enhanced detection of circulating tumor DNA by fragment size analysis , 2018, Science Translational Medicine.
[31] Ludmila V. Danilova,et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.
[32] Rajat Singhania,et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes , 2018, Nature.
[33] M. Ladanyi,et al. Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors , 2018, JAMA oncology.
[34] Steven J. M. Jones,et al. Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.
[35] PIWI proteins play oncogenic functions in pancreatic cancer. , 2019 .
[36] David R. Jones,et al. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants , 2019, Nature Medicine.
[37] H. Nielsen,et al. Genome-wide cell-free DNA fragmentation in patients with cancer , 2019, Nature.
[38] Ash A. Alizadeh,et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction , 2019, Cell.
[39] 1PPIWI proteins play oncogenic functions in pancreatic cancer. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] M. Ye,et al. Biological background of the genomic variations of cf-DNA in healthy individuals , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] Harry J de Koning,et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.
[42] Ash A. Alizadeh,et al. Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer , 2020, Nature Cancer.